Last updated:
"Wavy Cap, Blue Halos"
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/PsilocybeCyanescens-1_new-800x450.webp)
Psilocybe cyanescens, known commonly as the Wavy Cap, is a potent psychedelic mushroom recognized by its undulating cap edges and strong bluing reaction when bruised. Native to temperate regions, especially the Pacific Northwest of the United States and parts of Europe, it is rich in psilocybin and psilocin, the compounds responsible for its hallucinogenic effects.
First described in the mid-20th century, P. cyanescens gained popularity during the psychedelic movement of the 1960s and has since become one of the most widely known wild psilocybin species. It thrives in woodchip mulch and landscaped areas, often appearing in urban settings during the fall.
Historically, it has not been used in indigenous rituals like some other Psilocybe species, but modern psychonauts have embraced it for its strong visuals, intense introspective journeys, and potential therapeutic applications.
The mushroom typically has a caramel-colored cap, 1.5–5 cm wide, with a characteristic wavy margin as it matures. Its gills are closely spaced, turning from pale to dark purple-brown as spores develop. The stem is slender and whitish, bruising deep blue when damaged—a key indicator of psilocybin presence.
Due to its potency, even small amounts can produce profound effects, including visual distortions, altered perception of time, and emotional or spiritual experiences. It is illegal in many regions, but continues to be studied for potential use in treating mental health conditions like depression and PTSD.
Medium-sized with a convex shape, initially caramel-brown and becoming light brown with age, sometimes with a wavy edge
Initially pale yellow, maturing to dark brown
Users may experience changes in visual perception such as enhanced colors, geometric patterns, or distortions.
Users often report intense feelings of joy and happiness
Psilocybin has been shown to have antidepressant effects in clinical trials.
Psilocybin has been shown to have anxiolytic effects in clinical trials.
Psilocybin has been shown to have anti-addictive effects in clinical trials.
Psilocybin has been shown to have treat PTSD in clinical trials.
Psilocybin has been shown to improve attention and focus in clinical trials.
Psilocybin has been shown to reduce OCD symptoms in clinical trials.
Microdosing psilocybin has been shown to help with certain types of pain
Research shows that psilocybin, the active compound in magic mushrooms, has potential therapeutic benefits for migraines.4 A small-scale study conducted by Yale School of Medicine found that a single dose of psilocybin reduced the likelihood of having a migraine attack in two weeks.
Can cause stomach discomfort and nausea, especially when eaten raw.
Start your cultivation journey with quality grow kits from independent vendors
Key Differences: Psilocybe semilanceata has a more conical or bell-shaped cap and does not bruise blue as readily as Psilocybe cyanescens.
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/PsilocybeSemilanceata_new-400x400.webp)
(Liberty Cap)
4.0
(1)
Based on 1 Review
5
★4
★3
★2
★1
★If you've consumed this mushroom, share your thoughts with our community
01/29/2025
Anonymous